Metagenomi Therapeutics MGX
NASDAQ MGX
$0.82 -0.01 (-1.20%)
At close: Oct 22, 2026 · 4:00 PM EDT

Metagenomi Therapeutics (MGX) Other financing activities (2025 - 2026)

Updated

Metagenomi Therapeutics' Other financing activities came in at $7,000 for Q2 2026, down 97.5% from $275,000 a year earlier and down 74.1% from the prior quarter.

Analysis

Metagenomi Therapeutics (MGX) Other financing activities (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Metagenomi Therapeutics reported Other financing activities of $240,000; for FY2025, it came in at $558,000.

  • Business Quant data shows MGX's Other financing activities at $27,000 (Q1 2026), $19,000 (Q4 2025) and $187,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Metagenomi Therapeutics 30.98 Mn -574.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7,000.00
Mar 31, 2026 -27,000.00
Dec 31, 2025 -19,000.00
Sep 30, 2025 -187,000.00
Jun 30, 2025 -275,000.00
Mar 31, 2025 -77,000.00
API Access

Metagenomi Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MGX&period=max&api_key=YOUR_API_KEY